Covid-19 vaccination will start soon for the priority group. (Picture of IE, Representative) The government started testing the Covid-19 vaccination in most states. Soon, a part of the population will receive their first vaccine. Preparation for dosing at vaccine centers, logistical requirements, and other arrangements are also in full swing. …
Read More »286 sessions, 1.1 lakh of vaccinators trained on day 1
India today carried out a nationwide Covid-19 vaccine trial as the country approaches to begin its massive rollout of Covid-19 vaccination to the general public. The vaccine testing exercise took place amid news from the government panel of experts recommending emergency approval restricted to two Covid-19 vaccines that are manufactured …
Read More »The national drill begins tomorrow. Details here
On Saturday a simulation of the Covid-19 vaccination campaign will be carried out in all states and territories of the Union, according to the order of the central government. The exercise aims to test the preparation for the launch of the vaccine. A two-day test was carried out on December …
Read More »On Chennai’s Adverse Reaction Claim, Center Says No Need To Stop Vaccine Trial
Written by Kaunain Sheriff M | New Delhi | Updated: December 2, 2020 7:52:43 am At the Serum Institute of India on Monday. (Photo: Reuters) UNDERLINING THAT several controls have been put in place to track adverse reactions reported in clinical trials for the Covid vaccine candidate being developed by …
Read More »Serum to Present Rs 100 Million Case After Man’s Vaccine Trial Distress Claim | India News
The Serum Institute of India issued a statement Sunday about a participant in its Covid vaccine trial who became seriously ill during the trial, stating that “there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer.” Describing the allegations in the legal notice sent …
Read More »AstraZeneca Likely to Conduct Additional Global Covid-19 Vaccine Trial, CEO Says
AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company’s chief executive, after current studies raised questions about its level of protection. The new trial would be conducted rather than adding an arm to an ongoing trial in …
Read More »Serum Institute to Resume Vaccine Trials Following DCGI Approval | India News
MUMBAI: A day after Oxford University-AstraZeneca announced that trials of its proposed Coronavirus vaccine candidate have resumed, the Serum Institute said it is awaiting further instructions from the Indian drug regulator. Clinical trials for the AstraZeneca-Oxford coronavirus vaccine resumed in the UK after the Medicines Health Regulatory Authority (MHRA) confirmed …
Read More »Oxford and AstraZeneca to Resume Coronavirus Vaccine Trial: Why It Matters
The University of Oxford, one of the leading Covid-19 vaccine developers in the world race, resumed its trial to test the drug it is developing with pharmaceutical company AstraZeneca on Saturday. The restart to demonstrate the drug’s effectiveness comes two days after he had to stop the trial after a …
Read More »